Status:
WITHDRAWN
Platelet-rich Plasma Injection for Temporomandibular Disorders
Lead Sponsor:
Tri-Service General Hospital
Conditions:
Temporomandibular Disorder
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Temporomandibular disorder (TMD) involves the temporomandibular joint (TMJ) and surrounding structure, causing problems including myofascial pain and joint degeneration. TMD is mostly seen in the age ...
Detailed Description
Objectives: Temporomandibular disorder (TMD) involves the temporomandibular joint (TMJ) and surrounding structure, causing problems including myofascial pain and joint degeneration. TMD is mostly see...
Eligibility Criteria
Inclusion
- Age between 20-80 year-old.
- Duration of symptoms ( temporomandibular joint pain or tenderness, joint noise or joint motility dysfunction)more than 3 months.
- Diagnosis was confirmed by using the original Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) and the severity at least Grade II.
Exclusion
- Head and neck cancer
- Neurological disease
- Cognition impairment
- Coagulopathy
- Pregnancy
- Inflammation status
- Infection status
- Previously undergone wrist surgery or steroid injection for TMD
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04127942
Start Date
November 1 2019
End Date
April 30 2020
Last Update
April 27 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.